drugset / Trial / NCT03373266

Serun Fluoride and Kidney Transplant

NCT03373266

Phase 2 Completed 30 enrolled Assiut University
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

Our primary goal is to investigate any hidden burden upon the grafted kidney from the increase of serum fluoride resulted from sevoflurane, versus isoflurane.

Timeline

Start
2015-10
Primary completion
2017-08
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sevoflurane Other / unclassified 1 % Inhaled
Comparator Sevoflurane Other / unclassified 2 % Inhaled

Indications

No indication recorded.